Recent advances in the diagnosis and management of infection in the organ transplant recipient.
Infection remains a significant cause of morbidity and mortality in organ transplant patients, with significant infection being found in more than half of these individuals posttransplant. The most important principles of patient treatment are prevention, early diagnosis, and specific therapy. The nature of the antimicrobial therapy required both for infection prevention and treatment is closely linked to the immunosuppressive therapy being administered. A particular challenge in the transplant patient is that the antiinflammatory effects of antirejection therapy tend to obscure the manifestations of infection until relatively late in the disease process, thus putting particular emphasis on more aggressive diagnostic approaches-imaging procedures, biopsy, and new techniques for microbial detection (antigen and DNA detection). Antimicrobial therapy can be administered in three ways: therapeutically, prophylactically, and preemptively. Particularly given the propensity for adverse interactions between antimicrobial agents and cyclosporine and tacrolimus, there is a particular emphasis on prophylactic and preemptive use of antimicrobials.
Tolkoff-Rubin
N E
NE
Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Rubin
R H
RH
D000890:Anti-Infective Agents / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy; D007239:Infections / Q000175:diagnosis* / Q000628:therapy*; D009181:Mycoses; D016377:Organ Transplantation; D014777:Virus Diseases
D000890:Anti-Infective Agents